{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:59:37Z","timestamp":1781632777642,"version":"3.54.5"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,16]]},"DOI":"10.7759\/cureus.110975","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:36:06Z","timestamp":1781631366000},"source":"Crossref","is-referenced-by-count":0,"title":["Ovarian Carcinosarcoma With Heterologous Chondrosarcomatous Differentiation: A Case Report and Review of Literature"],"prefix":"10.7759","author":[{"given":"Amal","family":"Moukhtari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asmae","family":"Aissaoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anass","family":"Haloui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nassira","family":"Karich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amal","family":"Bennani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/01.gco.0000192997.27663.9e","article-title":"Malignant mixed M\u00fcllerian tumors of the ovary","volume":"18","author":"Navarini R","year":"2006","unstructured":"Navarini R, Pineda RL. Malignant mixed M\u00fcllerian tumors of the ovary. Curr Opin Obstet Gynecol. 2006, 18:20-3. 10.1097\/01.gco.0000192997.27663.9e","journal-title":"Curr Opin Obstet Gynecol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.55.5.321","article-title":"Malignant biphasic uterine tumours: carcinosarcomas or metaplastic carcinomas?","volume":"55","author":"McCluggage WG","year":"2002","unstructured":"McCluggage WG. Malignant biphasic uterine tumours: carcinosarcomas or metaplastic carcinomas?. J Clin Pathol. 2002, 55:321-5. 10.1136\/jcp.55.5.321","journal-title":"J Clin Pathol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2015.03.041","article-title":"Uterine carcinosarcoma: a review of the literature","volume":"137","author":"Cantrell LA","year":"2015","unstructured":"Cantrell LA, Blank SV, Duska LR. Uterine carcinosarcoma: a review of the literature. Gynecol Oncol. 2015, 137:581-8. 10.1016\/j.ygyno.2015.03.041","journal-title":"Gynecol Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2006.05.030","article-title":"Testing of two binary grading systems for FIGO stage III serous carcinoma of the ovary and peritoneum","volume":"103","author":"Seidman JD","year":"2006","unstructured":"Seidman JD, Horkayne-Szakaly I, Cosin JA, Ryu HS, Haiba M, Boice CR, Yemelyanova AV. Testing of two binary grading systems for FIGO stage III serous carcinoma of the ovary and peritoneum. Gynecol Oncol. 2006, 103:703-8. 10.1016\/j.ygyno.2006.05.030","journal-title":"Gynecol Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2013.06.034","article-title":"Carcinosarcoma of the ovary: natural history, patterns of treatment, and outcome","volume":"131","author":"George EM","year":"2013","unstructured":"George EM, Herzog TJ, Neugut AI, et al.. Carcinosarcoma of the ovary: natural history, patterns of treatment, and outcome. Gynecol Oncol. 2013, 131:42-5. 10.1016\/j.ygyno.2013.06.034","journal-title":"Gynecol Oncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/diseases13060163","article-title":"Recent developments in rare ovarian carcinosarcoma: literature review and case report","volume":"13","author":"Nienhaus A","year":"2025","unstructured":"Nienhaus A, Bernad E. Recent developments in rare ovarian carcinosarcoma: literature review and case report. Diseases. 2025, 13:10.3390\/diseases13060163","journal-title":"Diseases"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1408196","article-title":"Ovarian carcinosarcomas: p53 status defines two distinct patterns of oncogenesis and outcomes","volume":"14","author":"Dhillon G","year":"2024","unstructured":"Dhillon G, Llaurado-Fernandez M, Tessier-Cloutier B, et al.. Ovarian carcinosarcomas: p53 status defines two distinct patterns of oncogenesis and outcomes. Front Oncol. 2024, 14:1408196. 10.3389\/fonc.2024.1408196","journal-title":"Front Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2024.35.e31","article-title":"Incidence and treatment outcomes of ovarian carcinosarcoma from the national cancer registry of Korea","volume":"35","author":"Ha HI","year":"2024","unstructured":"Ha HI, Kim JH, Lim J, Song YJ, Won YJ, Lim MC. Incidence and treatment outcomes of ovarian carcinosarcoma from the national cancer registry of Korea. J Gynecol Oncol. 2024, 35:e31. 10.3802\/jgo.2024.35.e31","journal-title":"J Gynecol Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1399979","article-title":"Ovarian carcinosarcoma is highly aggressive compared to other ovarian cancer histotypes","volume":"14","author":"McFarlane I","year":"2024","unstructured":"McFarlane I, Porter JM, Brownsell E, Ghaoui N, Connolly KC, Herrington CS, Hollis RL. Ovarian carcinosarcoma is highly aggressive compared to other ovarian cancer histotypes. Front Oncol. 2024, 14:1399979. 10.3389\/fonc.2024.1399979","journal-title":"Front Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000004173","article-title":"Updates and new options in advanced epithelial ovarian cancer treatment","volume":"137","author":"Kurnit KC","year":"2021","unstructured":"Kurnit KC, Fleming GF, Lengyel E. Updates and new options in advanced epithelial ovarian cancer treatment. Obstet Gynecol. 2021, 137:108-21. 10.1097\/AOG.0000000000004173","journal-title":"Obstet Gynecol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdz062","article-title":"ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease","volume":"30","author":"Colombo N","year":"2019","unstructured":"Colombo N, Sessa C, du Bois A, et al.. ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease. Ann Oncol. 2019, 30:672-705. 10.1093\/annonc\/mdz062","journal-title":"Ann Oncol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.20256","article-title":"Carcinosarcoma of the ovary: 19 years of prospective data from a single center","volume":"100","author":"Brown E","year":"2004","unstructured":"Brown E, Stewart M, Rye T, et al.. Carcinosarcoma of the ovary: 19 years of prospective data from a single center. Cancer. 2004, 100:2148-53. 10.1002\/cncr.20256","journal-title":"Cancer"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.61","article-title":"Ovarian cancer","volume":"2","author":"Matulonis UA","year":"2016","unstructured":"Matulonis UA, Sood AK, Fallowfield L, Howitt BE, Sehouli J, Karlan BY. Ovarian cancer. Nat Rev Dis Primers. 2016, 2:16061. 10.1038\/nrdp.2016.61","journal-title":"Nat Rev Dis Primers"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1126\/science.1196333","article-title":"Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma","volume":"330","author":"Jones S","year":"2010","unstructured":"Jones S, Wang TL, Shih IeM, et al.. Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma. Science. 2010, 330:228-31. 10.1126\/science.1196333","journal-title":"Science"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9440(10)63708-x","article-title":"Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis","volume":"164","author":"Shih IeM","year":"2004","unstructured":"Shih IeM, Kurman RJ. Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis. Am J Pathol. 2004, 164:1511-8. 10.1016\/s0002-9440(10)63708-x","journal-title":"Am J Pathol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2017.02.010","article-title":"Integrated molecular characterization of uterine carcinosarcoma","volume":"31","author":"Cherniack AD","year":"2017","unstructured":"Cherniack AD, Shen H, Walter V, et al.. Integrated molecular characterization of uterine carcinosarcoma. Cancer Cell. 2017, 31:411-23. 10.1016\/j.ccell.2017.02.010","journal-title":"Cancer Cell"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.02050","article-title":"Randomized phase III trial of paclitaxel and carboplatin versus paclitaxel and ifosfamide in patients with carcinosarcoma of the uterus or ovary: an NRG oncology trial","volume":"40","author":"Powell MA","year":"2022","unstructured":"Powell MA, Filiaci VL, Hensley ML, et al.. Randomized phase III trial of paclitaxel and carboplatin versus paclitaxel and ifosfamide in patients with carcinosarcoma of the uterus or ovary: an NRG oncology trial. J Clin Oncol. 2022, 40:968-77. 10.1200\/JCO.21.02050","journal-title":"J Clin Oncol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.14712\/18059694.2024.13","article-title":"Spotlight on carcinosarcoma of the ovary: a scoping review","volume":"67","author":"Gauci M","year":"2024","unstructured":"Gauci M, Calleja-Agius J. Spotlight on carcinosarcoma of the ovary: a scoping review. Acta Medica (Hradec Kralove). 2024, 67:1-11. 10.14712\/18059694.2024.13","journal-title":"Acta Medica (Hradec Kralove)"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1097\/IGC.0000000000000228","article-title":"Gynecologic Cancer InterGroup (GCIG) consensus review for uterine and ovarian carcinosarcoma","volume":"24","author":"Berton-Rigaud D","year":"2014","unstructured":"Berton-Rigaud D, Devouassoux-Shisheboran M, Ledermann JA, et al.. Gynecologic Cancer InterGroup (GCIG) consensus review for uterine and ovarian carcinosarcoma. Int J Gynecol Cancer. 2014, 24:S55-60. 10.1097\/IGC.0000000000000228","journal-title":"Int J Gynecol Cancer"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1614120113","article-title":"Mutational landscape of uterine and ovarian carcinosarcomas implicates histone genes in epithelial-mesenchymal transition","volume":"113","author":"Zhao S","year":"2016","unstructured":"Zhao S, Bellone S, Lopez S, et al.. Mutational landscape of uterine and ovarian carcinosarcomas implicates histone genes in epithelial-mesenchymal transition. Proc Natl Acad Sci U S A. 2016, 113:12238-43. 10.1073\/pnas.1614120113","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/497470-ovarian-carcinosarcoma-with-heterologous-chondrosarcomatous-differentiation-a-case-report-and-review-of-literature","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:36:07Z","timestamp":1781631367000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/497470-ovarian-carcinosarcoma-with-heterologous-chondrosarcomatous-differentiation-a-case-report-and-review-of-literature"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,16]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.110975","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,16]]}}}